Screener
GeneDx Holdings WGS Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accrued compensation | $20,337 | $29,638 |
| Accrued severance | 742 | 771 |
| Due to related parties | 758 | 643 |
| Current portion of long-term debt | — | 4,542 |
| Short-term contingent consideration liability | 5,353 | 5,444 |
| Short-term warrant liability | 220 | 1,100 |
| Other | 8,538 | 4,721 |
| Total | $35,948 | $46,859 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is GeneDx Holdings's current debt?
- GeneDx Holdings (WGS) reported current debt of $0 in Q1 2026.
- How has GeneDx Holdings's current debt changed year-over-year?
- GeneDx Holdings's current debt decreased by 100.0% year-over-year, from $1.22M to $0.
- What is the long-term trend for GeneDx Holdings's current debt?
- Over 5 years (2020 to 2025), GeneDx Holdings's current debt has grown at a 20.7% compound annual growth rate (CAGR), from $1.77M to $4.54M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about GeneDx Holdings's current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude